DINESH

Apollo Hospital Enterprises

Industry: Healthcare
Latest CMP 8,920
Today's Change ▲ 3.85%
52-Week High / Low 9,039 | 6,777
Price Date: 14-Aug-2026
Recommendation Buy
Target Price 11,780
Expected Upside 14.9%
Forecast Horizon 2 Years
Historical CAGR 20.7%
1,000 Invested 15-Aug-2006
Today's Value 42,876
Investment Period 20 Years

Stock Snapshot

Post Results Return
-2.2%
Neutral Market Reaction
1-Year Target Price
10,952
2-Year Target Price
11,780
52-Week High / Low
9,039 / 6,777
20-Day Return
+0.3%
Market Cap (Cr.)
128,277
Current PE
64.4
P/BV Ratio
13.6
Dividend Yield
0.3%
Industry PE
57.2

Price Performance

Basis of our Recommendation

Apollo Hospitals is navigating a robust growth trajectory, bolstered by management's strategic focus on a significant capacity expansion plan, which aims to increase bed count to 14,100 by FY31. This expansion is expected to enhance revenue growth through improved occupancy rates and operational leverage in established facilities. Additionally, the company is prioritizing profitability in its digital and diagnostics segments, with management targeting break-even for Apollo 24/7 by Q2FY27. Despite facing near-term margin pressures from the ramp-up of new facilities and potential regulatory risks, the long-term outlook remains positive, supported by a stable pricing environment and increasing demand for organized healthcare services in India. Vista's financial outlook reflects stable revenue growth and margins, with a fair valuation aligned with intrinsic value. Over the next 12-24 months, key opportunities include the successful execution of the capacity expansion and the integration of digital health initiatives, while watchpoints include the gestation period of new hospital units and regulatory challenges. Overall, Apollo Hospitals is well-positioned to capitalize on the structural growth in the healthcare sector, despite the inherent risks associated with its aggressive expansion strategy

👍 Why We Like This Stock

  • Significant capacity expansion plan targeting 14,100 beds by FY31, enhancing revenue potential
  • Management's focus on achieving profitability in digital and diagnostics segments, with a clear roadmap for Apollo 24/7
  • Stable pricing power and increasing demand for organized healthcare services in India support long-term growth

Things To Watch Out For

  • Near-term margin pressures from the ramp-up of new facilities may impact profitability
  • Regulatory risks related to potential government-mandated price caps on hospital services
  • Execution risks associated with the gestation period of new hospital units and integration challenges

Key Parameters

Balance Sheet Strength
Stable Financial Structure
Market Share
Stable
Industry Outlook
Stable
Analyst View
Buy
Dividend History
Consistent
FII Holdings
Reducing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 19,059 21,794 25,228 27,147 31,369
Profit Before Tax (Cr.) 1,344 1,968 2,680 3,311 3,754
PBT Margin 7.1% 9.0% 1062.3% 12.2% 12.0%
Net Profit (Cr.) 922 1,465 2,046 2,519 2,772
Earnings Per Share 61.6 97.8 138.0 170.0 192.7

Analyst Recommendations

Broker Recommendation Target Price Date
Choice Equity ▲ Buy 9,600 22-May-2026
Citigroup ▲ Buy 10,770 13-Aug-2026
Elara Capital ► Accumulate 9,470 14-Aug-2026
Goldman Sachs ▲ Buy 8,850 22-May-2026
HDFC Securities ▲ Buy 9,680 22-May-2026
HSBC ▲ Buy 9,000 21-Apr-2026
ICICI Securities ► Hold 8,100 22-May-2026
Kotak Securities ▲ Buy 9,520 13-Aug-2026
Macguire ▼ Underperform 6,230 13-Aug-2026
Moneycontrol ► Equalweight nan 14-Aug-2026
Morgan Stanley ▲ Overweight 9,397 13-Aug-2026
Motilal Oswal ▲ Buy 10,160 14-Aug-2026
Prabhudas Liladhar ▲ Buy 10,000 14-Aug-2026
Consensus Recommendation ▲ Buy
Consensus Target 9,363
Coverage 13 Analysts
Analysts' Viewpoint
Apollo Hospitals' strong operational performance is supported by robust growth in its core hospital and digital segments, with a strategic focus on expanding bed capacity to 14,100 by FY31. Analysts highlight the company's improved operating leverage and digital health economics as key positives. However, potential government-mandated price caps and execution risks from new hospital ramp-ups pose significant challenges. Future catalysts include the breakeven of digital and insurance businesses and the launch of new hospital facilities, which are expected to enhance profitability.

Company Overview

Show Company Profile

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.